六块爱理不理 8块高攀不起查看全文
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioPharma(AYTU)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-003823 Act: 33 Size: 1 KB 网页链接
$Aytu BioPharma(AYTU)$ DEL AM Delaying amendment Accession Number: 0001558370-21-012883 Act: 33 Size: 8 KB 网页链接
$Aytu BioPharma(AYTU)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001558370-21-012833 Act: 33 Size: 1 MB 网页链接
$Aytu BioPharma(AYTU)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-21-012825 Act: 34 Size: 20 MB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-21-012772 Act: 34 Size: 388 KB 网页链接
$Aytu BioPharma(AYTU)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001011438-21-000210 Act: 34 Size: 67 KB 网页链接
$Aytu BioPharma(AYTU)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001011438-21-000208 Act: 34 Size: 71 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, item 5.02 Accession Number: 0001558370-21-012131 Act: 34 Size: 151 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001213900-21-031096 Act: 34 Size: 315 KB 网页链接
$Aytu BioPharma(AYTU)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001213900-21-031092 Act: 33 Size: 441 KB 网页链接